Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Opinion: Eli Lilly Stock Is a No-Brainer Pick to Buy on the Dip

Key PointsLilly's pipeline is packed with metabolic health programs.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

More from Wednesday 30 September →